Sanofi, Innovent Biologics ink pact to accelerate development of oncology medicines in China Ruchika Sharma7 Aug 2022 12:30 PM ISTIn addition to the collaboration and license agreement, Sanofi will invest €300 million in Innovent through subscription of new common shares.
Setback: Eli Lilly- Innovent lung cancer drug Sintilimab rejected by USFDA Ruchika Sharma26 March 2022 12:41 PM ISTFDA and its advisers had raised concerns over the lack of population diversity in a single-country trial.
NMPA approves Adalimumab Injection for Pediatric Plaque Psoriasis and Non-infectious Uveitis Hina Zahid27 Dec 2020 3:30 PM ISTChina -- National Medical Products Administration (NMPA) of China has approved adalimumab injection a recombinant human anti-TNF-α monoclonal...
